JP3118911U - Double room bag - Google Patents

Double room bag Download PDF

Info

Publication number
JP3118911U
JP3118911U JP2005010046U JP2005010046U JP3118911U JP 3118911 U JP3118911 U JP 3118911U JP 2005010046 U JP2005010046 U JP 2005010046U JP 2005010046 U JP2005010046 U JP 2005010046U JP 3118911 U JP3118911 U JP 3118911U
Authority
JP
Japan
Prior art keywords
chamber
storage chamber
diluent
drug
weak seal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2005010046U
Other languages
Japanese (ja)
Inventor
井上　冨士夫
立石　勇
陽人 戸川
達郎 鶴岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP2005010046U priority Critical patent/JP3118911U/en
Application granted granted Critical
Publication of JP3118911U publication Critical patent/JP3118911U/en
Priority to PCT/JP2006/319318 priority patent/WO2007063638A1/en
Priority to CN2006800444491A priority patent/CN101316568B/en
Priority to US12/085,734 priority patent/US20090299324A1/en
Priority to EP06810765A priority patent/EP1958608A4/en
Priority to ES06833278.2T priority patent/ES2579997T3/en
Priority to SG201007979-6A priority patent/SG166800A1/en
Priority to PCT/JP2006/323474 priority patent/WO2007063777A1/en
Priority to CN2006800447979A priority patent/CN101316569B/en
Priority to US12/084,821 priority patent/US9278051B2/en
Priority to KR1020087013648A priority patent/KR101258724B1/en
Priority to AU2006320033A priority patent/AU2006320033B2/en
Priority to EP06833278.2A priority patent/EP1955686B1/en
Priority to TW95143894A priority patent/TWI401076B/en
Priority to TW95144193A priority patent/TWI412357B/en
Priority to HK09104022.5A priority patent/HK1125557A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

【課題】薬剤を外部から明確に視認することができ、誤った投与の発生がなく、かつ、対環境性が良好で安価な複室バッグを提供する。
【解決手段】薬剤収容室１の一端側に弱シール部２を介して希釈液室３が連設される一方、前記薬剤収容室１の他端側に弱シール部２を介して口部４を有する空室５が連設される複室バッグであって、薬剤収容室１、希釈液室３及び空室５は、透明なフィルム材からなり、かつ、薬剤収容室１の外側が、透明なガスバリヤフィルム６で覆われる。
【選択図】 図２[Problem] To provide a multi-chamber bag in which a drug can be clearly visually recognized from the outside, does not cause erroneous administration, has good environmental properties, and is inexpensive.
A diluent chamber is connected to one end side of a medicine storage chamber via a weak seal portion, while a mouth portion is connected to the other end side of the drug storage chamber via a weak seal portion. A multi-chamber bag in which a vacant chamber 5 having a plurality of chambers is provided, wherein the drug container 1, the diluent chamber 3, and the vacant chamber 5 are made of a transparent film material, and the outer side of the drug chamber 1 is transparent. Covered with a new gas barrier film 6.
[Selection] Figure 2

Description

本考案は、薬剤と希釈液とを分離した状態で収容し、使用時に混合するようにした複室バッグに係り、詳しくは、外部から薬剤と希釈液の混合状態を明確に視認できるようにした複室バッグに関する。   The present invention relates to a multi-chamber bag in which a medicine and a diluent are stored separately and mixed at the time of use. Specifically, the state of mixing the medicine and the diluent can be clearly seen from the outside. It relates to a multi-chamber bag.

薬剤収容室と希釈液室の間に弱シール部を設け、使用時に薬剤と希釈液とを混合させるようにした複室バッグで、吸湿性や易酸化性を有する薬剤等を乾燥剤や脱酸素剤を使用することなく薬剤収容室に収容できるようにしたものは提案されている（例えば、特許文献１参照）。この例では、図示は省略するが、薬剤収容室の両側は、例えば、アルミ加工フィルムを含む多層フィルムで覆われ前面側のアルミ加工フィルムを剥離可能として、口部のある希釈液室を薬剤収容室の下に配置して吊した状態で希釈した薬剤を投与するように構成されている。   A multi-chamber bag with a weak seal between the drug storage chamber and the diluent chamber that mixes the drug with the diluent during use. An apparatus that can be accommodated in a medicine accommodating chamber without using an agent has been proposed (see, for example, Patent Document 1). In this example, although not shown, both sides of the drug storage chamber are covered with, for example, a multilayer film including an aluminum processed film so that the front aluminum processing film can be peeled off, and the diluent chamber with the mouth is stored in the drug storage chamber. It is configured to administer the diluted drug in a suspended state placed under the chamber.

特開平１１−２７６５４７号公報Japanese Patent Laid-Open No. 11-276547

しかし、上述のように、薬剤収容室が、アルミ加工フィルムを含む多層フィルムで覆われていると、外部から薬剤を視認することができないという難点がある。また、薬剤を希釈した際にその混合状態を確認するために前面側のアルミ加工フィルムを剥がす作業も面倒である。そして、希釈液室に口部が設けられていると、薬剤が希釈液に混合されない状態で投与されてしまうようなトラブルの発生も懸念される。さらに、アルミ加工フィルムが含まれているため、高価になるだけでなく、そのまま投棄できないという対環境性の問題もあった。   However, as described above, when the medicine storage chamber is covered with a multilayer film including an aluminum processed film, there is a problem that the medicine cannot be visually recognized from the outside. Moreover, in order to confirm the mixing state when the drug is diluted, the work of removing the aluminum processed film on the front side is also troublesome. If the mouth portion is provided in the diluent chamber, there is a concern that a trouble may occur such that the medicine is administered without being mixed with the diluent. Furthermore, since an aluminum processed film is included, not only is it expensive, but there is also an environmental problem that it cannot be discarded as it is.

本願考案は、このような実情に鑑みてなされ、薬剤を外部から明確に視認することができ、誤った投与の発生がなく、かつ、対環境性が良好で安価な複室バッグを提供することを目的とする。   The present invention is devised in view of such a situation, and provides a multi-chamber bag in which a medicine can be clearly visually recognized from the outside, there is no occurrence of erroneous administration, and the environment is good and inexpensive. With the goal.

（１）本考案の複室バッグは、薬剤収容室の一端側に弱シール部を介して希釈液室が連設される一方、前記薬剤収容室の他端側に弱シール部を介して口部を有する空室が連設される複室バッグであって、
前記薬剤収容室、希釈液室及び空室は、透明なフィルム材からなり、かつ、前記薬剤収容室を、気体及び液体を実質的に透過させない透明なガスバリヤフィルムで被覆してなることを特徴とする。 (1) In the multi-chamber bag of the present invention, a diluent chamber is connected to one end side of the drug storage chamber via a weak seal portion, and a mouth is connected to the other end side of the drug storage chamber via a weak seal portion. A multi-chamber bag in which vacancies having a portion are provided,
The drug storage chamber, the diluent chamber, and the vacant chamber are made of a transparent film material, and the drug storage chamber is covered with a transparent gas barrier film that does not substantially transmit gas and liquid. To do.

この構成においては、気体及び液体を実質的に透過させない透明なガスバリヤフィルムで薬剤収容室を被覆することで、乾燥剤や脱酸素剤を使用することなく、薬剤が酸素や水分の影響を受けないように保護することができ、そのガスバリヤフィルムが透明であることから、外部から薬剤収容室の内部を透視することができ、収容された薬剤の状態及び弱シール部を破断して希釈液室から薬剤収容室に希釈液を導入して薬剤に混合したときに不溶性異物の有無等を明確に確認することができる。このようなガスバリヤフィルムとしては、例えば、ポリエチレンテレフタレート（ＰＥＴ）にシリカ又はアルミナを蒸着したものをポリエチレン（ＰＥ）等のオレフィン系樹脂に貼着したものが好ましい。   In this configuration, the drug is not affected by oxygen or moisture without using a desiccant or oxygen scavenger by covering the drug storage chamber with a transparent gas barrier film that does not substantially allow gas and liquid to permeate. Since the gas barrier film is transparent, the inside of the medicine storage chamber can be seen through from the outside, and the state of the stored medicine and the weak seal portion are broken to remove from the dilution liquid chamber. When a diluent is introduced into the medicine storage chamber and mixed with the medicine, the presence or absence of insoluble foreign matter can be clearly confirmed. As such a gas barrier film, for example, a film in which silica or alumina is vapor-deposited on polyethylene terephthalate (PET) is attached to an olefin resin such as polyethylene (PE).

また、製造工程においても異物の混入等を明確に検出することができる。さらに、このような透明なガスバリヤフィルムで薬剤収容室を覆うので、例えば、両面印刷したラベルを希釈液室の片面に貼り付ければ、薬剤収容室と希釈液室を弱シール部で２つ折りにした状態でも、そのラベルを外部から透視して判読できる利点もある。   In addition, foreign matters can be clearly detected in the manufacturing process. In addition, since the drug storage chamber is covered with such a transparent gas barrier film, for example, if a double-side printed label is attached to one side of the diluent chamber, the drug chamber and the diluent chamber are folded in two at the weak seal portion. Even in the state, there is an advantage that the label can be read through from the outside.

そして、その薬剤収容室と弱シール部を介して口部を有する空室を連設しているため、必ず薬剤が希釈液で希釈された状態で空室を介して投与されるため、誤った投与の発生を防ぐことができる。また、ガスバリヤフィルムで覆われた薬剤収容室と弱シール部を介して口部を有する空室を連設しているため、口部及びその周辺においては、バリア性であることが要件とされず、その分材料費を低減することができる。さらに、従来のようなアルミ加工フィルムを用いていないため、安価に提供することができ、かつ、対環境性も向上し廃棄処分が容易となる利点もある。   And since the vacant chamber having the mouth portion is connected through the drug storage chamber and the weak seal portion, the drug is always administered through the vacant chamber in the state diluted with the diluent, Occurrence of administration can be prevented. In addition, since the medicine containing chamber covered with the gas barrier film and the vacant chamber having the mouth portion are connected through the weak seal portion, it is not a requirement that the mouth portion and its surroundings have barrier properties. The material cost can be reduced accordingly. Furthermore, since the conventional aluminum processed film is not used, there is an advantage that it can be provided at a low cost, is environmentally friendly, and is easily disposed of.

本考案の複室バッグは、弱シール部を介して希釈液室が連設される薬剤収容室に弱シール部を介して口部を有する空室を連設すると共に、薬剤収容室の外側を、気体及び液体を実質的に透過させない透明なガスバリヤフィルムで薬剤収容室を被覆するので、バリア性の向上が図られ、乾燥剤や脱酸素剤を使用することなく、薬剤が酸素や水分の影響を受けないようにすることができる。   The multi-chamber bag of the present invention has a vacant chamber having a mouth portion connected through a weak seal portion to a drug storage chamber in which a diluent solution chamber is connected through a weak seal portion, and an outer side of the drug storage chamber. Since the drug storage chamber is covered with a transparent gas barrier film that does not substantially allow gas and liquid to permeate, the barrier property is improved, and the effect of oxygen and moisture on the drug is eliminated without using a desiccant or oxygen scavenger. You can avoid it.

そして、外部から薬剤収容室の内部を透視することができ、収容された薬剤の状態及び薬剤に希釈液を混合したときに不溶性異物の有無等を明確に確認することができる。また、製造工程においても異物の混入等を外部から明確に検出することができる。さらに、例えば、両面印刷したラベルを希釈液室に貼り付ければ、薬剤収容室と希釈液室を弱シール部で２つ折りにした状態でも、そのラベルを外部から透視して判読できる利点もある。   Then, the inside of the medicine storage chamber can be seen through from the outside, and the state of the stored medicine and the presence or absence of insoluble foreign matter when the diluent is mixed with the medicine can be clearly confirmed. In addition, foreign matters can be clearly detected from the outside even in the manufacturing process. Further, for example, if a label printed on both sides is attached to the diluent chamber, there is an advantage that the label can be seen through from the outside even when the medicine storage chamber and the diluent chamber are folded in two at the weak seal portion.

また、必ず薬剤が希釈液で希釈された状態で空室を介して投与されるため、誤った投与の発生を防ぐことができる。また、口部及びその周辺においては、バリア性であることが要件とされず、その分材料費を低減することができる。さらに、従来のようなアルミ加工フィルムを用いていないため、安価に提供することができ、かつ、対環境性も向上し廃棄処分が容易となる利点もある。   In addition, since the drug is always administered through the empty chamber in a state diluted with a diluent, it is possible to prevent the occurrence of erroneous administration. Moreover, it is not a requirement for the barrier property at the mouth portion and its periphery, and the material cost can be reduced accordingly. Furthermore, since the conventional aluminum processed film is not used, there is an advantage that it can be provided at a low cost, is environmentally friendly, and is easily disposed of.

以下に、本考案の最良の実施の形態に係る複室バッグについて図面を参照しつつ詳細に説明する。
図１は複室バッグの正面図、図２は断面図、図３はフィルム材及びガスバリヤフィルムの断面図である。図１及び図２にて、符号１は、抗生剤等の各種薬剤を収納する薬剤収容室、２は弱シール部、３は希釈液室、４は口部、５は空室、６はガスバリアフィルム、７は吊り孔である。この複室バッグは、薬剤収容室１の一端側に弱シール部２を介して希釈液室３が連設される一方、前記薬剤収容室１の他端側に弱シール部２を介して口部４を有する空室５が連設され、薬剤収容室１、希釈液室３及び空室５は、透明なフィルム材からなり、かつ、薬剤収容室１の外側は、透明なガスバリヤフィルム６で覆われている。 The multi-chamber bag according to the best mode of the present invention will be described in detail below with reference to the drawings.
1 is a front view of a multi-chamber bag, FIG. 2 is a sectional view, and FIG. 3 is a sectional view of a film material and a gas barrier film. 1 and 2, reference numeral 1 denotes a drug storage chamber for storing various drugs such as antibiotics, 2 is a weak seal portion, 3 is a diluent chamber, 4 is a mouth portion, 5 is an empty chamber, and 6 is a gas barrier. A film 7 is a hanging hole. The multi-chamber bag has a diluent chamber 3 connected to one end side of the medicine storage chamber 1 via a weak seal portion 2, and is connected to the other end side of the medicine storage chamber 1 via a weak seal portion 2. A vacant chamber 5 having a portion 4 is continuously provided, the drug storage chamber 1, the diluent chamber 3 and the vacancy 5 are made of a transparent film material, and the outside of the drug storage chamber 1 is a transparent gas barrier film 6. Covered.

薬剤収容室１、希釈液室３及び空室５を形成するフィルム材は、例えば、図３（ａ）に示すように、内面側のポリエチレン（ＰＥ）とポリプロピレン（ＰＰ）の混合樹脂層（厚さ２０μｍ）１１、ポリエチレン（ＰＥ）層（厚さ６０μｍ）１２、シクロオレフィンコポリマー（ＣＯＣ）層又はシクロオレフィンポリマー（ＣＯＰ）層（厚さ２０μｍ）１３、ポリエチレン（ＰＥ）層（厚さ５０μｍ）１２からなる多層構成で、２枚のフィルム材の周縁部同士が溶着され、かつ、その薬剤収容室１と希釈液室３の間、及び、薬剤収容室１と空室５の間には、それぞれ弱シールが施されて弱シール部２，２が形成されている。   For example, as shown in FIG. 3A, the film material forming the drug containing chamber 1, the diluent chamber 3, and the empty chamber 5 is a mixed resin layer (thickness) of polyethylene (PE) and polypropylene (PP) on the inner surface side. , Polyethylene (PE) layer (thickness 60 μm) 12, cycloolefin copolymer (COC) layer or cycloolefin polymer (COP) layer (thickness 20 μm) 13, polyethylene (PE) layer (thickness 50 μm) 12 In the multi-layer configuration, the peripheral portions of the two film materials are welded to each other, and between the drug storage chamber 1 and the diluent chamber 3 and between the drug storage chamber 1 and the empty chamber 5, respectively. Weak seals 2 and 2 are formed by applying a weak seal.

一方、薬剤収容室１の外側を覆う透明なガスバリヤフィルム６は、例えば、図３（ｂ）に示すように、その内面側のポリエチレン（ＰＥ）（厚さ３０μｍ）のオレフィン系樹脂層６１に対して、接着剤層６３を介して、ポリエチレンテレフタレート（ＰＥＴ）（厚さ１５μｍ）６２にシリカ蒸着層６ａを蒸着したものを貼着して形成される。その層構成は、図３（ｃ）（ｄ）に示すように、多層であってもよい。即ち、図３（ｃ）に示す構成ではシリカ蒸着層６ａを３層に、図３（ｄ）に示す構成ではシリカ蒸着層６ａを６層に形成している。また、そのシリカ蒸着層６ａに代えて、アルミナ蒸着層６ｂを形成してもよく、例えば、図３（ｅ）では２層のアルミナ蒸着層６ｂを、図３（ｆ）では４層のアルミナ蒸着層６ｂを、図３（ｇ）では８層のアルミナ蒸着層６ｂを、それぞれ形成している。   On the other hand, the transparent gas barrier film 6 covering the outside of the medicine storage chamber 1 is, for example, as shown in FIG. 3 (b) against the olefin resin layer 61 of polyethylene (PE) (thickness 30 μm) on the inner surface side. Then, an adhesive layer 63 is formed by adhering polyethylene terephthalate (PET) (thickness 15 μm) 62 having a silica vapor deposition layer 6a deposited thereon. The layer structure may be a multilayer as shown in FIGS. That is, in the configuration shown in FIG. 3C, the silica vapor deposition layer 6a is formed in three layers, and in the configuration shown in FIG. 3D, the silica vapor deposition layer 6a is formed in six layers. Further, instead of the silica vapor deposition layer 6a, an alumina vapor deposition layer 6b may be formed. For example, in FIG. 3 (e), two alumina vapor deposition layers 6b are formed, and in FIG. In FIG. 3G, the layer 6b is formed with eight alumina vapor-deposited layers 6b.

このようなガスバリヤフィルム６は、酸素透過度１ｃｃ／ｍ2 ・ｄａｙ・ａｔｏｍ以下、水分透過度１ｇ／ｍ2 ・ｄａｙ（４０℃，９０％ＲＨ）以下であることが好ましい。このような透明のガスバリヤフィルム６で薬剤収容室１の外側を覆うことによって、乾燥剤や脱酸素剤を使用することなく、薬剤が酸素や水分の影響を受けないようにすることができる。なお、ガスバリヤフィルム６は薬剤収容室１の周縁部に対して溶着されればよい。 Such a gas barrier film 6 preferably has an oxygen permeability of 1 cc / m 2 · day · atom or less and a moisture permeability of 1 g / m 2 · day (40 ° C., 90% RH) or less. By covering the outside of the medicine storage chamber 1 with such a transparent gas barrier film 6, it is possible to prevent the medicine from being influenced by oxygen and moisture without using a desiccant or an oxygen scavenger. The gas barrier film 6 may be welded to the peripheral edge of the medicine storage chamber 1.

そのガスバリヤフィルム６が透明であることから、外部から薬剤収容室１の内部を透視することができ、収容された薬剤の状態及び弱シール部２を破断して希釈液室３から薬剤収容室１に希釈液を導入して薬剤に混合したときに不溶性異物の有無等を明確に確認することができる。また、製造工程においても異物の混入等を明確に検出することができる。さらに、このような透明なガスバリヤフィルム６で薬剤収容室１を覆うので、例えば、両面印刷したラベルを希釈液室３の片面に貼り付ければ、薬剤収容室１と希釈液室３を弱シール部２で２つ折りにした状態でも、また、投与時に吊した状態でも、そのラベルを外部から透視して判読できる利点もある。   Since the gas barrier film 6 is transparent, the inside of the medicine storage chamber 1 can be seen through from the outside, the state of the stored medicine and the weak seal portion 2 are broken, and the medicine storage chamber 1 is separated from the diluent chamber 3. The presence or absence of insoluble foreign matter can be clearly confirmed when the diluent is introduced into the mixture and mixed with the drug. In addition, foreign matters can be clearly detected in the manufacturing process. Furthermore, since the medicine storage chamber 1 is covered with such a transparent gas barrier film 6, for example, if a double-side printed label is attached to one side of the diluent chamber 3, the medicine chamber 1 and the diluent chamber 3 are weakly sealed. There is also an advantage that the label can be seen through from the outside even in a state where it is folded in two or hung at the time of administration.

その薬剤収容室１と弱シール部２を介して口部４を有する空室５を連設しているため、必ず薬剤が希釈液で希釈された状態で空室５を介して投与されるため、誤った投与の発生を防ぐことができる。また、ガスバリヤフィルム６で覆われた薬剤収容室１と弱シール部２を介して口部４を有する空室５を連設しているため、口部４及びその周辺においては、バリア性であることが要件とされず、その分材料費を低減することができる。さらに、従来のようなアルミ加工フィルムを用いていないため、安価に提供することができ、かつ、対環境性も向上し廃棄処分が容易となる利点もある。   Since the medicine chamber 1 and the vacant chamber 5 having the mouth portion 4 are connected through the weak seal portion 2, the medicine is always administered through the vacant chamber 5 in a state diluted with a diluent. Can prevent the occurrence of incorrect administration. In addition, since the medicine chamber 1 covered with the gas barrier film 6 and the vacant chamber 5 having the mouth portion 4 through the weak seal portion 2 are continuously provided, the mouth portion 4 and the periphery thereof have a barrier property. Therefore, the material cost can be reduced accordingly. Furthermore, since the conventional aluminum processed film is not used, there is an advantage that it can be provided at a low cost, is environmentally friendly, and is easily disposed of.

なお、本考案は、実施の形態に限定されることなく、考案の要旨を逸脱しない限りにおいて、適宜、必要に応じて、設計変更や改良等を行うのは自由であり、また、各実施の形態間での流用・転用も自由である。   It should be noted that the present invention is not limited to the embodiment, and it is free to make design changes and improvements as necessary, as long as it does not depart from the gist of the invention. Diversion and diversion between forms is also free.

本考案の実施の形態に係る複室バッグの正面図である。It is a front view of the multi-chamber bag which concerns on embodiment of this invention. 同断面図である。FIG. （ａ）同フィルム材の層構成を示す断面図、（ｂ）単層のシリカ蒸着層、（ｃ）３層のシリカ蒸着層、（ｄ）６層のシリカ蒸着層、（ｅ）２層のアルミナ蒸着層、（ｆ）４層のアルミナ蒸着層、（ｇ）８層のアルミナ蒸着層、をそれぞれ有するガスバリヤフィルムの層構成を示す断面図である。(A) Cross-sectional view showing the layer structure of the film material, (b) single-layer silica deposited layer, (c) three-layer silica deposited layer, (d) six-layer silica deposited layer, (e) two-layer It is sectional drawing which shows the layer structure of the gas barrier film which has an alumina vapor deposition layer, (f) 4 layers of alumina vapor deposition layers, and (g) 8 layers of alumina vapor deposition layers, respectively.

符号の説明Explanation of symbols

１…薬剤収容室、２…弱シール部、３…希釈液室、４…口部、５…空室、６…ガスバリヤフィルム、６１…オレフィン系樹脂、６２…ポリエチレンテレフタレート（ＰＥＴ）   DESCRIPTION OF SYMBOLS 1 ... Drug storage chamber, 2 ... Weak seal part, 3 ... Diluent chamber, 4 ... Mouth part, 5 ... Empty room, 6 ... Gas barrier film, 61 ... Olefin resin, 62 ... Polyethylene terephthalate (PET)

Claims (2)

薬剤収容室の一端側に弱シール部を介して希釈液室が連設される一方、前記薬剤収容室の他端側に弱シール部を介して口部を有する空室が連設される複室バッグであって、
前記薬剤収容室、希釈液室及び空室は、透明なフィルム材からなり、かつ、前記薬剤収容室を、気体及び液体を実質的に透過させない透明なガスバリヤフィルムで被覆してなることを特徴とする複室バッグ。 A dilution chamber is connected to one end side of the drug storage chamber via a weak seal portion, while a vacant chamber having a mouth portion is connected to the other end side of the drug storage chamber via a weak seal portion. A room bag,
The drug storage chamber, the diluent chamber, and the vacant chamber are made of a transparent film material, and the drug storage chamber is covered with a transparent gas barrier film that does not substantially transmit gas and liquid. Double room bag to do. 前記ガスバリヤフィルムは、ポリエチレンテレフタレート（ＰＥＴ）にシリカ又はアルミナを蒸着したものをポリエチレン（ＰＥ）等のオレフィン系樹脂に貼着して形成されることを特徴とする請求項１に記載の複室バッグ。   2. The multi-chamber bag according to claim 1, wherein the gas barrier film is formed by attaching silica or alumina deposited on polyethylene terephthalate (PET) to an olefin resin such as polyethylene (PE). 3. .
JP2005010046U 2005-11-29 2005-11-29 Double room bag Expired - Lifetime JP3118911U (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
JP2005010046U JP3118911U (en) 2005-11-29 2005-11-29 Double room bag
PCT/JP2006/319318 WO2007063638A1 (en) 2005-11-29 2006-09-28 Multichamber bag and gas barrier film
CN2006800444491A CN101316568B (en) 2005-11-29 2006-09-28 Multi-chamber-bag and air block film
US12/085,734 US20090299324A1 (en) 2005-11-29 2006-09-28 Multichamber Bag and Gas Barrier Film
EP06810765A EP1958608A4 (en) 2005-11-29 2006-09-28 Multichamber bag and gas barrier film
EP06833278.2A EP1955686B1 (en) 2005-11-29 2006-11-24 Method of reinforcing soft sealing part of multicell container for medical use
PCT/JP2006/323474 WO2007063777A1 (en) 2005-11-29 2006-11-24 Method of reinforcing soft sealing part of multicell container for medical use
SG201007979-6A SG166800A1 (en) 2005-11-29 2006-11-24 Method for reinforcing weak sealed portion of multi-chamber medical container
ES06833278.2T ES2579997T3 (en) 2005-11-29 2006-11-24 Method for reinforcing a weak sealing part of a multi-chamber medical container
CN2006800447979A CN101316569B (en) 2005-11-29 2006-11-24 Reinforcement method for weak seal section of medical multi-chamber container
US12/084,821 US9278051B2 (en) 2005-11-29 2006-11-24 Method for reinforcing weak sealed portion of multi-chamber medical container
KR1020087013648A KR101258724B1 (en) 2005-11-29 2006-11-24 Method of reinforcing soft sealing part of multicell container for medical use
AU2006320033A AU2006320033B2 (en) 2005-11-29 2006-11-24 Method for reinforcing weak sealed portion of multi-chamber medical container
TW95143894A TWI401076B (en) 2005-11-29 2006-11-28 Method for reinforcing weak sealed portion of multi-chamber medical container
TW95144193A TWI412357B (en) 2005-11-29 2006-11-29 Mult-chamber bag and gas-barrier film
HK09104022.5A HK1125557A1 (en) 2005-11-29 2009-04-30 Method of reinforcing soft sealing part of multicell container for medical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005010046U JP3118911U (en) 2005-11-29 2005-11-29 Double room bag

Publications (1)

Publication Number Publication Date
JP3118911U true JP3118911U (en) 2006-02-09

Family

ID=40111013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005010046U Expired - Lifetime JP3118911U (en) 2005-11-29 2005-11-29 Double room bag

Country Status (2)

Country Link
JP (1) JP3118911U (en)
CN (2) CN101316568B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007136062A1 (en) * 2006-05-23 2007-11-29 Nipro Corporation Container
CN101415620B (en) * 2006-03-31 2011-06-15 株式会社大塚制药工厂 Multi-chamber container

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009009876B4 (en) * 2009-02-20 2012-05-16 Kuhne Anlagenbau Gmbh Single-layer or multi-layer, smokable, air-dry, tubular food film for food packaging and method for its production
JP5628020B2 (en) * 2010-12-20 2014-11-19 テルモ株式会社 Method for producing individual package for medical bag and individual package for medical bag
WO2017151906A2 (en) * 2016-03-03 2017-09-08 Juicero, Inc. Juicer cartridge with burstable seal
CN105857867A (en) * 2016-05-03 2016-08-17 贵州瑞龙集团塑料包装有限公司 Nano-composite film bag capable of realizing one-way venting and high obstruction
FR3058638B1 (en) * 2016-11-16 2022-01-14 Technoflex DOUBLE COMPARTMENT MEDICAL POUCH WITH TAB
CN107199734A (en) * 2017-06-06 2017-09-26 石家庄鹏海制药股份有限公司 The production technology of big soft infusion bag
CN109987321A (en) * 2017-12-29 2019-07-09 山东园元智能装备制造有限公司 A kind of multicell packaging bag and solid-liquid dispense composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068136A1 (en) * 2002-02-14 2003-08-21 Otsuka Pharmaceutical Factory, Inc. Medical multi-chamber container

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101415620B (en) * 2006-03-31 2011-06-15 株式会社大塚制药工厂 Multi-chamber container
WO2007136062A1 (en) * 2006-05-23 2007-11-29 Nipro Corporation Container

Also Published As

Publication number Publication date
CN101316569B (en) 2012-02-29
CN101316568B (en) 2012-10-03
CN101316568A (en) 2008-12-03
CN101316569A (en) 2008-12-03

Similar Documents

Publication Publication Date Title
JP3118911U (en) Double room bag
WO2007063638A1 (en) Multichamber bag and gas barrier film
JP3131605U (en) Double room bag
JP3419139B2 (en) Flexible multi-chamber container
JP5056754B2 (en) container
KR101258724B1 (en) Method of reinforcing soft sealing part of multicell container for medical use
JP5171823B2 (en) Double room bag
WO1995025010A1 (en) Contamination-proof sealant film and product fabricated therefrom
WO2013084515A1 (en) Tablet packaging body
JP2013183952A (en) Tablet package
JP5183974B2 (en) Packaging bag
JP3112358U (en) High barrier container
CN110077708B (en) Protective film for multi-chamber container, and method for manufacturing multi-chamber container
JP4649854B2 (en) Drug bag
JP2007244864A (en) Multiple chamber container
JP6210273B2 (en) Packing body for medical multi-chamber container and packing method for the same
US20210162723A1 (en) Lid material for blister packs
KR200442565Y1 (en) Multichamber bag and gas barrier film
JP5053620B2 (en) Reinforcing method for weak seals in medical multi-chamber containers
JP2019089561A5 (en)
JPH10201822A (en) Multilayer sealant film for medical treatment and its production
JP2019089561A (en) Lid material for blister packs
JP2004329433A (en) Double chamber container
JP2003116963A (en) Medical container
JP2008132100A (en) Packaging bag for liquid bag and liquid bag package

Legal Events

Date Code Title Description
R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090118

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120118

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120118

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150118

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term